Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹2,163 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹2,163 Cr
Mar2025₹1,911 Cr
Mar2024₹1,656 Cr
Mar2023₹1,245 Cr
Mar2022₹777 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹2,163 Cr
13.19
Mar2025 ₹1,911 Cr
15.39
Mar2024 ₹1,656 Cr
33.02
Mar2023 ₹1,245 Cr
60.22
Mar2022 ₹777 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹149,799.5 Cr -1.8% -0.1% 36.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,794.0 Cr 1.7% -2.3% 8% Stock Analytics
DIVIS LABORATORIES ₹178,956.0 Cr 2% -2.2% 1.5% Stock Analytics
CIPLA ₹109,370.0 Cr -2% -3.3% -9.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,133.0 Cr -0.6% -3.8% -6.9% Stock Analytics
MANKIND PHARMA ₹99,835.6 Cr 1.5% -6.4% 1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.8%

-0.1%

36.7%

SENSEX

1.7%

2.1%

-6%


You may also like the below Video Courses